ExodusPoint Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-18,988
| Closed | -$5.22M | – | 1346 |
|
|
2024
Q3 | $5.22M | Buy |
+18,988
| New | +$5.22M | 0.03% | 371 |
|
|
2024
Q2 | – | Sell |
-18,658
| Closed | -$2.79M | – | 1352 |
|
|
2024
Q1 | $2.79M | Buy |
+18,658
| New | +$2.79M | 0.02% | 487 |
|
|
2023
Q2 | – | Sell |
-13,953
| Closed | -$2.8M | – | 1732 |
|
|
2023
Q1 | $2.8M | Buy |
+13,953
| New | +$2.8M | 0.02% | 658 |
|
|
2022
Q4 | – | Sell |
-3,122
| Closed | -$625K | – | 1552 |
|
|
2022
Q3 | $625K | Sell |
3,122
-7,541
| -71% | -$1.51M | 0.01% | 1256 |
|
|
2022
Q2 | $1.56M | Buy |
+10,663
| New | +$1.56M | 0.02% | 850 |
|
|
2022
Q1 | – | Sell |
-5,745
| Closed | -$974K | – | 2090 |
|
|
2021
Q4 | $974K | Buy |
+5,745
| New | +$974K | 0.01% | 1048 |
|
|
2021
Q3 | – | Sell |
-23,458
| Closed | -$3.98M | – | 2007 |
|
|
2021
Q2 | $3.98M | Buy |
23,458
+696
| +3% | +$118K | 0.04% | 389 |
|
|
2021
Q1 | $3.21M | Buy |
22,762
+19,661
| +634% | +$2.78M | 0.05% | 375 |
|
|
2020
Q4 | $403K | Buy |
+3,101
| New | +$403K | ﹤0.01% | 1306 |
|
|
2020
Q1 | – | Sell |
-23,876
| Closed | -$2.75M | – | 1012 |
|
|
2019
Q4 | $2.75M | Buy |
+23,876
| New | +$2.75M | 0.05% | 224 |
|